University of Utah Transplant and Cellular Therapy Program at Huntsman Cancer Institute
Locations
Transplant Summary
Overview
Our program uses a multidisciplinary team approach in providing comprehensive medical care pre- and post-treatment to patients and families in order to optimize outcomes and patient satisfaction. The team consists of attending physicians fellows advanced practice clinicians nurse coordinators clinic nurses donor coordinators social workers physical therapists and quality support. This center has been performing allogeneic transplants since 1990 has been an NMDP transplant center since September 1992 and accredited by FACT since 1990.This center has been performing allogeneic transplants since 1991 and has been an NMDP transplant center since September 1992.
Attending physicians
Adult - Daniel Couriel, Lauren Lee, Brian McClune, Patel Sagar
Pediatric - Soohee Cho, Candi Deimundo-Roura, Joseph Gregory Dolan, Amanda Johnson, Michele Nassin, Michael Pulsipher, Ahmad RayesTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult and pediatricOther programs and services
Ronald McDonald housing short term housing, Integrative medicine programs, Wellness Clinic, school programs, Chronic graft v. host clinic, Late Effects Clinic Parent and family support groups.Patient survival information for this center
Utah Blood and Marrow Transplant Program- Adults
This center's actual 1-year survival results are below the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 149 patients.The actual 1-year survival of these patients is 66.3%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 67.5% and 80.8%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.Utah Blood and Marrow Transplant Program-Peds
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 73 patients.The actual 1-year survival of these patients is 80.3%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 78% and 93.6%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
288
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow17PBSC37Cord blood0Total54Unrelated donorMarrow4PBSC42Cord blood0Total46Total allogeneicMarrow21PBSC79Cord blood0Total100AutologousMarrowBoth marrow & PBSC 188PBSC—Cord blood—Total188Total combinedMarrowBoth marrow & PBSC 288PBSC—Cord blood0Total288Total pediatric transplants
98
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow31PBSC9Cord blood0Total40Unrelated donorMarrow20PBSC4Cord blood0Total24Total allogeneicMarrow51PBSC13Cord blood0Total64AutologousMarrowBoth marrow & PBSC 34PBSC—Cord blood—Total34Total combinedMarrowBoth marrow & PBSC 98PBSC—Cord blood0Total98All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-183719-441745-642865+12Total94Unrelated 0-182219-44945-641865+21Total70Autologous 0-183419-443845-648965+61Total222Total 0-189319-446445-6413565+94Total386Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
Transplant center coordinatorFrancesca PaglionePhone: (801) 587-4653NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
University of Utah Transplant and Cellular Therapy Program at Huntsman Cancer Institute and Intermountain Primary Children's Hospital
1950 Circle of Hope Salt Lake City, UT 84103 Phone:801-587-4652 For more information about this program: https://healthcare.utah.edu/huntsmancancerinstitute/treatment/blood-marrow-transplant (Opens in a new tab)Overview
The LTFU program provides comprehensive and multidisciplinary care for patients who have received a stem cell transplant or other cellular therapy while following the academic missions of the Program, including education and research.
Staff
Program Director:Daniel Couriel, MDProgram Coordinator:Tabitha Willie, Patient CoordinatorMedical Specialties in Program
Allergy/immunology, cardiology, dentistry, endocrinology, gastroenterology, hematology, hepatology.Medical Services Offered
Financial counseling, genetic counseling, nutrition/dietetics, occupational therapy, pain management.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic transplant recipients
- Adults: 90 days post for transplant and CAR-T cell therapy after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital